Logo IRD
Base Horizon

Publications des scientifiques de l'IRD

Notice fdi:010037792

Alexander N., Sutherland C., Roper C., Cissé Badara, Schellenberg D. Modelling the impact of intermittent preventive treatment for malaria on selection pressure for drug resistance - art. no. 9. Malaria Journal, 2007, 6, p. NIL_1-NIL_6. ISSN 1475-2875

Accès réservé (Intranet IRD) Document en accès réservé (Intranet IRD)

Lien direct chez l'éditeur doi:10.1186/1475-2875-6-9

TitreModelling the impact of intermittent preventive treatment for malaria on selection pressure for drug resistance - art. no. 9
Année de publication2007
Type de documentArticle référencé dans le Web of Science : 000244359200001
AuteursAlexander N., Sutherland C., Roper C., Cissé Badara, Schellenberg D.
SourceMalaria Journal, 2007, 6, p. NIL_1-NIL_6. ISSN 1475-2875
RésuméBackground: Intermittent preventive treatment (IPT) is a promising intervention for malaria control, although there are concerns about its impact on drug resistance. Methods: The key model inputs are age-specific values for a) baseline anti-malarial dosing rate, b) parasite prevalence, and c) proportion of those treated with anti-malarials ( outside IPT) who are infected. These are used to estimate the immediate effect of IPT on the genetic coefficient of selection (s). The scenarios modelled were year round IPT to infants in rural southern Tanzania, and three doses at monthly intervals of seasonal IPT in Senegal. Results: In the simulated Tanzanian setting, the model suggests a high selection pressure for drug resistance, but that IPTi would only increase this by a small amount (4.4%). The percent change in s is larger if parasites are more concentrated in infants, or if baseline drug dosing is less common or less specific. If children aged up to five years are included in the Tanzanian scenario then the predicted increase in s rises to 31%. The Senegalese seasonal IPT scenario, in children up to five years, results in a predicted increase in s of 16%. Conclusion: There is a risk that the useful life of drugs will be shortened if IPT is implemented over a wide childhood age range. On the other hand, IPT delivered only to infants is unlikely to appreciably shorten the useful life of the drug used.
LocalisationFonds IRD [F A010037792]
Informations Contact
IRD - base Horizon / Pleins textes Mentions légales Flux RSS

Export des données

Le fonds documentaire IRD

72 000 publications des scientifiques de l'IRD, dont 40 000 accessibles en ligne.

Consultation du fonds IRD :

Autres centres de documentation :